Bioprinting News and Research

RSS

Bioprinting involves the use of 3D printing technology to build tissues and organs. Bioprinting precisely places cells, proteins, DNA, drug particles, growth factors and biologically active particles spatially to guide tissue generation and formation. It has been used extensively in the field of regenerative medicine.

3D bioprinting methods for fabricating bioengineered blood vessel models

A review paper by scientists at the Chonnam National University summarized the recent research on bioprinting methods for fabricating bioengineered blood vessel models.

8 Sep 2023

Beyond traditional models: 3D bioprinted tumor microenvironment unlocks resistance insights

Researchers developed a three-dimensional (3D) biologically printed in vitro model of the breast cancer tumor microenvironment.

28 Aug 2023

Nanoengineered bioink improves tumor model accuracy

Scientists from the Terasaki Institute for Biomedical Innovation have developed a nanoengineered bioink with improved bonding and cross-linking capabilities for 3D bioprinting of tumor models.

3 Aug 2023

HU3DINKS project to develop human tissue-based bioinks for 3D bioprinting

Biofabrication or 3D bioprinting aims to create tissue constructs for numerous applications including animal free testing, drug screening and regenerative medicine.

28 Jul 2023

AXT and CELLINK Form a Formidable Australian Bioprinting Partnership

3D bioprinting is experiencing rapid growth as the technology continues to evolve. This is certainly the case in Australia and AXT, who are already well entrenched in the field are pleased to announce that they are strengthening their position by partnering with CELLINK.

From AXT Pty Ltd 25 Jul 2023

Penn state researchers receive $2 million NIH grant to develop new bioprinting technology

Developing technology to quickly and efficiently bioprint human tissues at scale is the goal of a new project led by Penn State researchers.

21 Jul 2023

Researchers develop 3D bioprinting technology for eliminating cancer cells

A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for the first time in the world.

11 Jul 2023

Next step in Sartorius partnership finalized: Several subsales and distribution agreements as well as R&D project agreements have been signed

During May and June 2023 several sub-sales and distribution agreements were signed between Sartorius and BICO companies CELLINK, Advanced BioMatrix (ABM) and Dispendix.

From BICO 5 Jul 2023

Volumetric bioprinting combined with melt electrowriting to create functional blood vessels

In this project volumetric bioprinting was for the first time successfully combined with melt electrowriting.

7 Jun 2023

New strategy to grow and measure how tumor organoids respond to therapy

Scientists from the UCLA Jonsson Comprehensive Cancer Center have developed a new method to bioprint miniature tumor organoids that are designed to mimic the function and architecture of real tumors. The improved process allows researchers to use an advanced imaging method to study and analyze individual organoids in great detail, which can help researchers identify personalized treatments for people with rare or hard-to-treat cancers.

7 Jun 2023

CELLINK Unveils Third Generation LUMEN X – The New Standard for DLP Bioprinting

CELLINK today announced the release of the third generation of their LUMEN X™ product – the new standard for benchtop DLP bioprinting.

From CELLINK 5 May 2023

Bioprinting combined with AI allows to obtain high-quality homogenized in vitro models

In the process of organoid manufacturing, bioprinting technology can not only facilitate the creation and maintenance of complex biological 3D shapes and structures, but also allow for standardization and quality control during production.

11 Apr 2023

3D Printing the Way to New Cancer Treatments

In this interview, we speak to Ishani Malhotra, CEO of Carcinotech, about their 3D-printed tumor replicas that are being used to better understand personalized cancer treatments.

3 Apr 2023

Innovative method to spot bacteria in blood, wastewater, and more

Shine a laser on a drop of blood, mucus, or wastewater, and the light reflecting back can be used to positively identify bacteria in the sample.

3 Mar 2023

Inventia Life Science collaborates with MSD to develop 3D advanced cell models for neurodegenerative disease drug discovery

Inventia Life Science, a world leader in advanced cell models for biomedical research and drug discovery, today announced a collaboration with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) using Inventia’s RASTRUM™ 3D cell culture platform.

From Inventia Life Science 16 Feb 2023

Using patches of synthetic skin to test blood-sucking behavior of mosquitoes

If watching animals feast on human blood for 30-plus hours isn't your idea of fun, don't worry. The robot can do it.

9 Feb 2023

Cellular models based on reprogrammed human cells could boost development of efficient therapies

Studies on diseases that affect the human brain are usually based on animal models which cannot reproduce the complexity of human neuropathies.

22 Dec 2022

NIH scientists use patient stem cells and 3D bioprinting to produce eye tissue

Scientists used patient stem cells and 3D bioprinting to produce eye tissue that will advance understanding of the mechanisms of blinding diseases.

22 Dec 2022

Using 3D patient tumor avatars to guide cancer treatment decisions

At any time, most cancer patients are receiving a treatment that does not significantly benefit them while enduring bodily and financial toxicity.

20 Dec 2022

'Stem cell plasters' could revolutionize treatment for children with congenital heart disease

Researchers at the University of Bristol funded by the British Heart Foundation (BHF) have developed 'stem cell plasters' to revolutionize the way surgeons treat children living with congenital heart disease, so they don't need as many open-heart operations.

20 Dec 2022

Bioprinting News and Research

Further Reading

3D bioprinting methods for fabricating bioengineered blood vessel models

Beyond traditional models: 3D bioprinted tumor microenvironment unlocks resistance insights

Nanoengineered bioink improves tumor model accuracy

HU3DINKS project to develop human tissue-based bioinks for 3D bioprinting

AXT and CELLINK Form a Formidable Australian Bioprinting Partnership

Penn state researchers receive $2 million NIH grant to develop new bioprinting technology

Researchers develop 3D bioprinting technology for eliminating cancer cells

Next step in Sartorius partnership finalized: Several subsales and distribution agreements as well as R&D project agreements have been signed

Volumetric bioprinting combined with melt electrowriting to create functional blood vessels

New strategy to grow and measure how tumor organoids respond to therapy

CELLINK Unveils Third Generation LUMEN X – The New Standard for DLP Bioprinting

Bioprinting combined with AI allows to obtain high-quality homogenized in vitro models

3D Printing the Way to New Cancer Treatments

Innovative method to spot bacteria in blood, wastewater, and more

Inventia Life Science collaborates with MSD to develop 3D advanced cell models for neurodegenerative disease drug discovery

Using patches of synthetic skin to test blood-sucking behavior of mosquitoes

Cellular models based on reprogrammed human cells could boost development of efficient therapies

NIH scientists use patient stem cells and 3D bioprinting to produce eye tissue

Using 3D patient tumor avatars to guide cancer treatment decisions

'Stem cell plasters' could revolutionize treatment for children with congenital heart disease

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring